Osimertinib a new weapon in epidermal growth factor receptor-mutated non-small cell lung cancer patients

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)S610-S613
JournalTranslational Cancer Research
Volume6
DOIs
Publication statusPublished - May 1 2017

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this